Behavioral and neurochemical vulnerability during adolescence in mice: Studies with nicotine

Neuropsychopharmacology

Volumn 29, Issue 5, 2004, Pages 869-878

  Adriani, Walter ^a   Granstrem, Oleg ^b,c   Macri, Simone ^a   Izykenova, Galina ^b,c   Dambinova, Svetlana ^b,c   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^c EMORY UNIVERSITY   (United States)

Author keywords

Addiction; Adolescence; AMPA receptors; Immunoreactivity; Mice; Nicotine; Plus maze; Vulnerability

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; N METHYL DEXTRO ASPARTIC ACID; NICOTINE; PROTEIN SUBUNIT; WATER;

ADOLESCENT; ADULTHOOD; AGE; ANIMAL EXPERIMENT; ANXIETY DISORDER; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE PREDISPOSITION; DRUG DEPENDENCE; DRUG EXPOSURE; FEMALE; HABITUATION; HUMAN; IMMUNOREACTIVITY; LOCOMOTION; LONG TERM EXPOSURE; MALE; MAZE TEST; MOUSE; NONHUMAN; ONTOGENY; POSTNATAL CARE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TIME SERIES ANALYSIS;

AGING; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; BODY WEIGHT; BRAIN CHEMISTRY; DOWN-REGULATION; DRINKING BEHAVIOR; EXPLORATORY BEHAVIOR; MAZE LEARNING; MICE; NICOTINE; NICOTINIC AGONISTS; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; UP-REGULATION;

EID: 1942420860     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300366     Document Type: Article

References (53)

1. Adriani W, Chiarotti F, Laviola G (1998). Elevated novelty seeking and peculiar D-amphetamine sensitization in periadolescent mice compared to adult mice. Behav Neurosci 112: 1152-1166.
2. Adriani W, Laviola G (2000). A unique profile of behavioral and hormonal hyporesponsivity in periadolescent mice. Neuropharmacology 39: 334-346.
3. Adriani W, Laviola G (2003). Elevated levels of impulsivity and reduced place conditioning with D-amphetamine: two behavioral features of adolescence in mice. Behav Neurosci 117: 695-703.
4. Adriani W, Macri S, Pacifici R, Laviola G (2002). Peculiar vulnerability to nicotine oral self-administration in mice during early adolescence. Neuropsychopharmacology 27: 212-224.
5. Adriani W, Spijker S, Deroche-Gamonet V, Laviola G, Le Moal M, Smit AB et al (2003). Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J Neurosci 23: 4712-4716.
6. Anthony JC, Petronis KR (1995). Early-onset drug use and risk of later drug problems. Drug Alcohol Dependence 40: 9-15.
7. Arnett J (1992). Reckless behavior in adolescence: a developmental perspective. Dev Rev 12: 339-373.
8. Balfour DJK, Benwell MEM, Birrell CE, Kelly RJ, Al-Aloul M (1998). Sensitization of the mesoaccumbens dopamine response to nicotine. Pharmacol Biochem Behav 59: 1021-1030.
9. Breslau N, Peterson EL (1996). Smoking cessation in young adults: age at initiation of cigarette smoking and other suspected influences. Am J Public Health 86: 214-220.
10. Brioni JD, O'Neill AB, Kim DJB, Decker MW (1993). Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur J Pharmacol 238: 1-8.
11. Burns LH, Everitt BJ, Kelley AE, Robbins TW (1994). Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology 115: 516-528.
12. Cheeta S, Irvine EE, Tucci S, Sandhu J, File SE (2001). In adolescence, female rats are more sensitive to the anxiolytic effect of nicotine than are male rats. Neuropsychopharmacology 25: 601-607.
13. Chiarotti F, Alleva E, Bignami G (1987). Problems of test choice and data analysis in behavioral teratology: the case of prenatal benzodiazepines. Neurobehav Toxicol Teratol 9: 179-186.
14. 2+ dependent mechanism. Neuropharmacology 39: 2799-2807.
15. DiCiano P, Cardinal RN, Cowell RA, Little SJ, Everitt BJ (2001). Differential involvment of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior. J Neurosci 21: 9471-9477.
16. DiCiano P, Everitt BJ (2001). Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 25: 341-360.
17. DiFranza JR, Rigotti NA, McNeill AD, Ockene JK, Savageau JA StCyr D, Coleman M (2000). Initial symptoms of nicotine dependence in adolescents. Tobacco Control 9: 313-319.
18. D'Souza DN, Harlan RE, Garcia MM (1999). Sexual dimorphism in the response to N-methyl-D-aspartate receptor antagonists and morphine on behavior and c-Fos induction in the rat brain. Neuroscience 93: 1539-1547.
19. Faraday MM, Elliott BM, Grunberg NE (2001). Adult vs adolescent rats differ in biobehavioral responses to chronic nicotine administration. Pharmacol Biochem Behav 70: 475-489.
20. Fasano S, Brambilla R (2002). Cellular mechanisms of striatum-dependent behavioral plasticity and drug addiction. Curr Mol Med 2: 649-665.
21. Ferris CF, Shtiegman K, King JA (1998). Voluntary ethanol consumption in male adolescent hamsters increases testosterone and aggression. Physiol Behav 63: 739-744.
22. File SE, Kenny PJ, Ouagazzal AM (1998). Anxiolytic and anxiogenic effects of nicotine in the social interaction test: role of dorsal hippocampus. Behav Neurosci 112: 1423-1429.
23. Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM (2003). It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 26: 184-192.
24. Holmes A, Rodgers RJ (1999). Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci Biobehav Rev 23: 971-980.
25. Kandel DB, Yamaguchi K, Chen K (1992). Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway drug theory. J Study Alcohol 53: 447-457.
26. Laviola G, Macri' S, Morley-Fletcher S, Adriani W (2003). Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci Biobehav Rev 27: 19-31.
27. Macri' S, Adriani W, Chiarotti F, Laviola G (2002). Risk-taking during exploration of a plus-maze is greater in adolescent than in juvenile or adult mice. Anim Behav 64: 541-546.
28. Mansvelder HD, McGehee D (2002). Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 53: 606-617.
29. Meyer EL, Gahring LC, Rogers SW (2002). Nicotine preconditioning antagonizes activity-dependent caspase proteolysis of a glutamate receptor. J Biol Chem 277: 10869-10875.
30. Nestler EJ (2001). Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2: 119-128.
31. Nestler EJ (2002). Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Memory 78: 637-647.
32. O'Neil AB, Brioni JD (1994). Benzodiazepine receptor mediation of the anxiolitic-like effect of (-)-nicotine in mice. Pharmacol Biochem Behav 49: 755-757.
33. Piazza PV, Maccari S, Deminiere JM, Le Moal M, Mormede P, Simon H (1991). Corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci USA 88: 2088-2092.
34. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM et al (1998). Acetylcholine receptors containing the beta 2 subunit are involved in the reinforcing properties of nicotine. Nature 391: 173-177.
35. Prendergast MA, Harris BR, Mayer S, Holey RC, Hauser KF, Littleton JM (2001). Chronic nicotine exposure reduces NMDA receptor-mediated damage in the hippocampus without altering calcium accumulation or extrusion: evidence of calbindin-D28K overexpression. Neuroscience 102: 75-85.
36. Robbins TW, Everitt BJ (2002). Limbic-striatal memory systems and drug addiction. Neurobiol Learn Memory 78: 625-636.
37. Robins LN, Przybeck TR (1985). Age of onset of drug use as a factor in drug and other disorders. In: Jones CL, Battjes RL (eds). Etiology of Drug Abuse: Implications for Prevention, NIDA Research Monograph, NIH publication: Rockville, MD, Vol 56, 178-192.
38. Schilstrom B, Nomikos GG, Nisell M, Hertel P, Svensson TH (1998). N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience 82: 781-789.
39. Slotkin TA (2002). Nicotine and the adolescent brain: insights from an animal model. Neurotoxicol Teratol 24: 369-384.
40. Spear LP (2000). The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24: 417-463.
41. Spear LP, Brake SC (1983). Periadolescence: age-dependent behavior and psycho-pharmacological responsivity in rats. Dev Psychobiol 16: 83-109.
42. Stamford JA (1989). Development and ageing of the rat nigrostriatal dopamine system studied with fast cyclic voltammetry. J Neurochem 52: 1582-1589.
43. Sutton MA, Schmidt EF, Chol KH, Schad CA, Whisler K, Simmons D et al (2003). Extinction-induced upregulation in AMPA receptots reduces cocaine-seeking behaviour. Nature 421: 70-75.
44. Taioli E, Wynder EL (1991). The importance of age of starting smoking. N Engl J Med 325: 968-969.
45. Teicher MH, Andersen SL, Hostetter JC (1995). Evidence for dopamine receptor pruning between adolescence and adulthood in striatum but not nucleus accumbens. Dev Brain Res 89: 167-172.
46. Torabi MR, Bailey WJ, Majd-Jabbari M (1993). Cigarette smoking as a predictor of alcohol and other drug use by children and adolescents: evidence of the 'gateway' drug effect. J Health 63: 302-306.
47. Trauth JA, Seidler FJ, Ali SF, Slotkin TA (2001). Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. Brain Res 892: 269-280.
48. Trauth JA, Seidler FJ, McCook EC, Slotkin TA (1999). Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res 851: 9-19.
49. Wills TA, Vaccaro D, McNamara G (1994). Novelty seeking, risk taking, and related constructs as predictors of adolescent substance use: an application of Cloninger's theory. J Subst Abuse 6: 1-20.
50. Winder DG, Egli RE, Schramm NL, Matthews RT (2002). Synaptic plasticity in drug reward circuitry. Curr Mol Med 2: 667-676.
51. Wise RA (1996). Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19: 319-340.
52. Wise RA, Bozarth MA (1987). A psychomotor stimulant theory of addiction. Psychol Rev 94: 469-492.
53. Zhang X, Gong ZH, Nordberg A (1994). Effects of chronic treatment wilh (+)-and (-)-nicotine on nicotinic acetylcholine receptors and N-methyl-D-aspartate receptors in rat brain. Brain Res 644: 32-39.